Background -Patients affected during the asthma outbreaks caused by soybean dust inhalation in Barcelona presented with sudden onset of severe asthma foliowed by the rapid relief of symptoms after treatment. Two years after the epidemics ended, a case-control study was conducted in which the clinical, functional, and immunological characteristics of these asthma patients (a randomised sample of asthmatic patients admitted as emergency cases on epidemic days, n = 213) were compared with those of a control group (a random sample of asthmatic patients admitted as emergency cases for attacks of asthma on non-epidemic days, n = 170). Methods -The study included the administration of the ATS-DLD78 standardised respiratory questionnaire, the measurement of atopy, and performance of spirometric tests and a methacholine inhalation test. Results -Patients with epidemic asthma reported fewer symptoms of asthma, had attended emergency departments less frequently during the previous year for acute attacks of asthma, were taking fewer inhaled corticosteroids at the time of the study, and attended medical foliow up less frequently than did the patients with nonepidemic asthma. However, the cases and controls showed no differences in ventilatory capacity or reactivity to the methacholine bronchoprovocation test. Conclusions -Two years after the end of the soybean epidemics, people affected by epidemic asthma had a favourable prognosis. This finding contrasts with a higher risk of life threatening asthma and death during the epidemics. This paradox could be the result of a complex interaction between host and conditions of exposure.
Abstract
Background -Patients affected during the asthma outbreaks caused by soybean dust inhalation in Barcelona presented with sudden onset of severe asthma foliowed by the rapid relief of symptoms after treatment. Two years after the epidemics ended, a case-control study was conducted in which the clinical, functional, and immunological characteristics of these asthma patients (a randomised sample of asthmatic patients admitted as emergency cases on epidemic days, n = 213) were compared with those of a control group (a random sample of asthmatic patients admitted as emergency cases for attacks of asthma on non-epidemic days, n = 170). Methods -The study included the administration of the ATS-DLD78 standardised respiratory questionnaire, the measurement of atopy, and performance of spirometric tests and a methacholine inhalation test. Results -Patients with epidemic asthma reported fewer symptoms of asthma, had attended emergency departments less frequently during the previous year for acute attacks of asthma, were taking fewer inhaled corticosteroids at the time of the study, and attended medical foliow up less frequently than did the patients with nonepidemic asthma. However, the cases and controls showed no differences in ventilatory capacity or reactivity to the methacholine bronchoprovocation test. Conclusions -Two years after the end of the soybean epidemics, people affected by epidemic asthma had a favourable prognosis. This The elimination of asthma epidemics, which coincided with the enforcement of dust control regulations at the silo in Barcelona harbour in 1987,7 has enabled us to study subjects who suffered asthma in conditions which probably were similar to those before the onset of the epidemics. We considered whether there were any significant differences between the characteristics of the asthma in the patients in the epidemic and non-epidemic groups two years after the end of the outbreaks, and whether those affected during the epidemics had characteristics which made them generally more susceptible to acute severe asthma.
Methods
The study population was made up of patients over 14 years of age resident in Barcelona, who had been admitted to hospital emergency departments with an acute attack of asthma during the 1981-7 epidemics. Patients were selected from those registered in the "respiratory emergency room system of Barcelona" developed to investigate the asthma epidemics. 8 Two 68 6 *Odds ratio adjusted by age and sex. Additional adjustment for smoking did not change the magnitude or the statistical significance of these odds ratios. 1) . After adjusting for smoking the differences for skin reactivity to any allergen changed from 2-62 to 2-75, whereas for specific allergens no changes occurred.
Baseline spirometric values were similar for cases and controls. The mean (SD) FEV, (% predicted) was 70 (24 7) in the cases and 69-6 (25 4) in controls, and the FVC was 84-5 and 86-5 (18-9), respectively. No differences were found between the two groups when baseline FEV, values were stratified according to age, sex, and smoking habit.
Of the 288 subjects in whom baseline spirometric tests were performed, 50 were excluded from the methacholine inhalation test because baseline FEV, was less than 40% of predicted, 13 declined to participate, and five did not complete the test. In eight cases and 11 controls the baseline FEV, fell >20% after saline administration. The percentage of subjects who showed a fall < 20% of baseline FEV, at each dose of methacholine was similar in all groups (fig 2) . The prevalence of bronchial hyperreactivity (PC20 < 25 mg/ml) was 94 5% in the cases and 92-2% in controls (58 1% of cases and 66 1% of controls had a severe hyperreactivity [PC20 < 1 mg/ml], p = NS). In the group of 50 patients in whom the methacholine inhalation test could not be performed, a bronchodilator test was administered to 39 subjects: baseline FEV, increased by 15% or more in 12 (52 2%) cases and in 16 (56 2%) controls.
No differences were found in the types of medication taken at the time ofthe study except for inhaled corticosteroids which were taken by fewer of the patients with epidemic asthma (34 3% v 49 0%; p<001) (table 3) . Patients with epidemic asthma also took medication and underwent medical follow up less frequently than did patients with non-epidemic asthma.
Logistic regression analysis (table 4) showed that the previously described differences between cases and controls in age, smoking history, symptoms of asthma, atopy, and taking inhaled corticosteroids persisted after simultaneous adjustment.
Discussion
In a previous paper aimed at identifying risk factors of epidemic soybean asthma apart from soybean dust inhalation, we found that patients with epidemic asthma were older, more likely to be male, and more skin reactive to common aeroallergens.'2 The male predominance was partially explained by the smoking habit which also appeared to constitute a risk factor. These characteristics have been reported in the New Orleans asthma epidemics, although the specific causative factor was not established. '3 In the present study we assessed possible differences in clinical, functional, and immunological characteristics between patients with epidemic and non-epidemic asthma.
Compared with controls, the patients with epidemic asthma had fewer symptoms of asthma during the previous year, had been admitted to emergency departments for asthma in the previous year on fewer occasions, and had needed treatment with inhaled steroids less frequently. The Our results suggest that, two years after the elimination of the epidemics, those people affected had a favourable prognosis. This con trasts with a higher risk of life threatening asthma and death during the epidemics. This paradox could be the result of a complex interaction between host and exposure. Host conditions and, in particular, a higher prevalence of atopy, made people more susceptible to sensitisation by soybean dust and to the development of soybean asthma. We suggest that the circumstances ofexposure or the nature of the allergen might have been responsible for the unusual severity of the attacks of soybean epidemic asthma.
